Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East

References

• International Society of Aesthetic Plastic Surgery (ISAPS). ISAPS international survey on aesthetic/cosmetic procedures performed in 2019. Available from: https://www.isaps.org/wp-content/uploads/2020/12/Global-Survey-2019.pdf. Accessed January 8, 2023.
   Google Scholar
• The middle east population; 2022. Available from: https://worldpopulationreview.com/continents/the-middle-east-population. Accessed June 16, 2022.
   Google Scholar
• Kashmar M, Alsufyani MA, Ghalamkarpour F, et al. Consensus opinions on facial beauty and implications for aesthetic treatment in Middle Eastern women. Plast Reconstr Surg Glob Open. 2019;7(4):e2220. doi:10.1097/GOX.0000000000002220
   PubMedGoogle Scholar
• Yutskovskaya Y, Gubanova E, Khrustaleva I, et al. IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations. Clin Cosmet Investig Dermatol. 2015;8:297–306. doi:10.2147/CCID.S72301
   PubMedGoogle Scholar
• Sundaram H, Huang PH, Hsu NJ, et al; Pan-Asian Aesthetics Toxin Consensus Group. Aesthetic applications of botulinum toxin A in Asians: an international, multidisciplinary, pan-asian consensus. Plast Reconstr Surg Glob Open. 2016;4(12):e872. doi:10.1097/GOX.0000000000000507
   PubMedGoogle Scholar
• Sundaram H, Signorini M, Liew S, et al.; Global Aesthetics Consensus Group. Global aesthetics consensus: botulinum toxin type a--evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 2016;137(3):518e–529e. doi:10.1097/01.prs.0000475758.63709.23
   PubMed Web of Science ®Google Scholar
• Farkas LG, Katic MJ, Forrest CR, et al. International anthropometric study of facial morphology in various ethnic groups/races. J Craniofac Surg. 2005;16(4):615–646. doi:10.1097/01.scs.0000171847.58031.9e
   PubMed Web of Science ®Google Scholar
• Al-Sebaei MO. The validity of three neo-classical facial canons in young adults originating from the Arabian Peninsula. Head Face Med. 2015;11(1):4. doi:10.1186/s13005-015-0064-y
   PubMedGoogle Scholar
• El Minawi H, El Saloussy Y, Sabry M, Wahdan W, El Sharkawy O. Facial anthropometry and analysis in Egyptian women. Plast Reconstr Surg Glob Open. 2022;10(5):e4333. doi:10.1097/GOX.0000000000004333
   PubMedGoogle Scholar
• Samizadeh S, De Boulle K. Botulinum neurotoxin formulations: overcoming the confusion. Clin Cosmet Investig Dermatol. 2018;11:273–287. doi:10.2147/CCID.S156851
   PubMed Web of Science ®Google Scholar
• Kerscher M, Roll S, Becker A, Wigger-Alberti W. Comparison of the spread of three botulinum toxin type A preparations. Arch Dermatol Res. 2012;304(2):155–161. doi:10.1007/s00403-011-1179-z
   PubMed Web of Science ®Google Scholar
• Grein S, Mander GJ, Fink K. Stability of botulinum neurotoxin type A, devoid of complexing proteins. Botulinum J. 2011;2(1):49–58. doi:10.1504/TBJ.2011.041815
   Google Scholar
• Carr WW, Jain N, Sublett JW. Immunogenicity of botulinum toxin formulations: potential therapeutic implications. Adv Ther. 2021;38(10):5046–5064. doi:10.1007/s12325-021-01882-9
   PubMed Web of Science ®Google Scholar
• Fathallah AM, Bankert RB, Balu-Iyer SV. Immunogenicity of subcutaneously administered therapeutic proteins--a mechanistic perspective. AAPS J. 2013;15(4):897–900. doi:10.1208/s12248-013-9510-6
   PubMed Web of Science ®Google Scholar
• Bellows S, Jankovic J. Immunogenicity associated with botulinum toxin treatment. Toxins. 2019;11(9):491. doi:10.3390/toxins11090491
   PubMed Web of Science ®Google Scholar
• Kerscher M, Wanitphakdeedecha R, Trindade de Almeida A, Maas C, Frevert J. IncobotulinumtoxinA: a highly purified and precisely manufactured botulinum neurotoxin type A. J Drugs Dermatol. 2019;18(1):52–57.
   PubMed Web of Science ®Google Scholar
• Carey WD. Incorrect reconstitution of incobotulinumtoxinA leads to loss of neurotoxin. J Drugs Dermatol. 2014;13(6):735–738.
   PubMed Web of Science ®Google Scholar
• Niamtu J. Neurotoxin waste from drawing product through the vial stopper. J Clin Aesthet Dermatol. 2014;7(6):33–37.
   PubMedGoogle Scholar
• Thomas JP, Siupsinskiene N. Frozen versus fresh reconstituted botox for laryngeal dystonia. Otolaryngol Head Neck Surg. 2006;135(2):204–208. doi:10.1016/j.otohns.2006.04.001
   PubMed Web of Science ®Google Scholar
• Soares DJ, Dejoseph LM, Zuliani GF, Liebertz DJ, Patel VS. Impact of postreconstitution room temperature storage on the efficacy of incobotulinumtoxinA treatment of dynamic lateral canthus lines. Dermatol Surg. 2015;41(6):712–717. doi:10.1097/DSS.0000000000000365
   PubMed Web of Science ®Google Scholar
• Wright G, Lax A, Mehta SB. A review of the longevity of effect of botulinum toxin in wrinkle treatments. Br Dent J. 2018;224(4):255–260. doi:10.1038/sj.bdj.2018.126
   PubMed Web of Science ®Google Scholar
• Frevert J. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products. Drugs R D. 2015;15(1):1–9. doi:10.1007/s40268-014-0077-1
   PubMed Web of Science ®Google Scholar
• Car H, Bogucki A, Bonikowski M, et al. Botulinum toxin type-A preparations are not the same medications — basic science (Part 1). Neurol Neurochir Pol. 2021;55(2):133–140. doi:10.5603/PJNNS.a2021.0027
   PubMed Web of Science ®Google Scholar
• DYSPORT® Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125274s107lbl.pdf. Accessed October 3, 2023.
   Google Scholar
• BOTOX© Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103000s5232lbl.pdf. Accessed October 3, 2023.
   Google Scholar
• XEOMIN© Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125360s078lbl.pdf. Accessed October 3, 2023.
   Google Scholar
• Carruthers A, Carruthers J, Cohen JL. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter? Dermatol Surg. 2007;33(1):S97–S104. doi:10.1111/j.1524-4725.2006.32339.x
   PubMedGoogle Scholar
• Trindade De Almeida AR, Secco LC, Carruthers A. Higher dilution associated with higher diffusion and less efficacy. Handling botulinum toxins: an updated literature review. Dermatol Surg. 2011;37(H):1553–1565. doi:10.1111/j.1524-4725.2011.02087.x
   PubMedGoogle Scholar
• Cohen JL, Ozog DM, Editors. Botulinum Toxins: Cosmetic and Clinical Applications. First ed. JohnWiley & Sons Ltd; 2017. Available from: www.wiley.com/go/cohen/botulinum. Accessed October 3, 2023.
   Google Scholar
• Kaidbey KH, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin, a comparison of black and Caucasian skin. J Am Acad Dermatol. 1979;1(3):249–260. doi:10.1016/S0190-9622(79)70018-1
   PubMed Web of Science ®Google Scholar
• Hexsel DM, Hexsel CL, Brunetto LI. Botulinum toxin. In: Grimes PE, editor. Aesthetic and Cosmetic Surgery for Darker Skin Types. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:211–224.
   Google Scholar
• Montagna W, Prota G, Kenney J. The structure of black skin. In: Montagna W, Prota G, Kenney J, editors. Black Skin Structure and Function. Gulf Professional Publishing; 1993.
   Google Scholar
• Sugino K, Imokawa G, Maibach H. Ethnic differences in stratum corneum lipid in relation to stratum corneum function. J Invest Dermatol. 1993;100:594.
   Web of Science ®Google Scholar
• Yi KH, Lee JH, Hu HW, Kim HJ. Anatomical proposal for botulinum neurotoxin injection for glabellar frown lines. Toxins. 2022;14(4):268. doi:10.3390/toxins14040268
   PubMed Web of Science ®Google Scholar
• Yi KH, Lee JH, Kim GY, Yoon SW, Oh W, Kim HJ. Novel anatomical proposal for botulinum neurotoxin injection targeting lateral canthal rhytids. Toxins. 2022;14(7):462. doi:10.3390/toxins14070462
   PubMed Web of Science ®Google Scholar
• Amiri L, Galadari H, Al Mugaddam F, Souid AK, Stip E, Javaid SF. Perception of cosmetic procedures among Middle Eastern Youth. J Clin Aesthet Dermatol. 2021;14(12):E74–E83.
   PubMedGoogle Scholar
• Yi KH, Lee JH, Lee K, Hu HW, Lee HJ, Kim HJ. Anatomical proposal for botulinum neurotoxin injection targeting the platysma muscle for treating platysmal band and jawline lifting: a review. Toxins. 2022;14(12):868. doi:10.3390/toxins14120868
   PubMed Web of Science ®Google Scholar
• Phan K, Younessi S, Dubin D, Lin MJ, Khorasani H. Emerging off-label esthetic uses of botulinum toxin in dermatology. Dermatol Ther. 2022;35(1):e15205. doi:10.1111/dth.15205
   PubMed Web of Science ®Google Scholar
• Baker A. Off-label cosmetic use of botulinum toxin in the lower face. Pmfa News|February/March 2016|Vol 3 No 3; 2016.
   Google Scholar
• Munavalli GS, Benedetto AV, Biesman BS, Cutler Peck CM. Treatment of the periocular area – crow’s feet, brow, and bunny lines. In: Cohen JL, Ozog DM, editors. Botulinum Toxins: Cosmetic and Clinical Applications. Wiley Online Library;2017. doi:10.1002/9781118661833.ch12
   Google Scholar
• Shirshakova M, Morozova E, Sokolova D, Pervykh S, Smirnova L. The effectiveness of botulinum toxin type A (BTX-A) in the treatment of facial skin oily seborrhea, enlarged pores, and symptom complex of post-acne. Int J Dermatol. 2021;60(10):1232–1241. doi:10.1111/ijd.15574
   PubMed Web of Science ®Google Scholar
• Allen S, Sengelmann R, Simmons R. Treatment of the perioral area. In: Cohen JL, Ozog DM, editors. Botulinum Toxins: Cosmetic and Clinical Applications. Wiley Online Library;2017. doi:10.1002/9781118661833.ch14
   Google Scholar
• Yi KY, Lee JH, Hu HW, Kim HJ. Novel anatomical guidelines on botulinum neurotoxin injection for wrinkles in the nose region. Toxins. 2022;14(5):342. doi:10.3390/toxins14050342
   PubMed Web of Science ®Google Scholar
• Hur MS, Lee S, Jung HS, Schneider RA, Cray JJ. Anatomical connections among the depressor supercilii, levator labii superioris alaeque nasi, and inferior fibers of orbicularis oculi: implications for variation in human facial expressions. PLoS One. 2022;17(3):e0264148. doi:10.1371/journal.pone.0264148
   PubMed Web of Science ®Google Scholar
• Yi KH, Lee JH, Hu HW, et al. Novel anatomical guidelines for botulinum neurotoxin injection in the mentalis muscle: a review. Anat Cell Biol. 2023;56(3):293–298. doi:10.5115/acb.22.266
   PubMed Web of Science ®Google Scholar
• Choi DY, Bae H, Bae JH, Kim HJ, Hu KS. Effective locations for injecting botulinum toxin into the mentalis muscle; cadaveric and ultrasonographic study. Toxins. 2021;13(2):96. doi:10.3390/toxins13020096
   PubMed Web of Science ®Google Scholar
• Yi KH, Lee JH, Hu HW, et al. Novel anatomical proposal for botulinum neurotoxin injection targeting depressor anguli oris for treating drooping mouth corner. Anat Cell Biol. 2023;56(2):161–165. doi:10.5115/acb.22.258
   PubMed Web of Science ®Google Scholar
• Kaufman-Janette J, Cox SE, Dayan S, Joseph J. Botulinum toxin type a for glabellar frown lines: what impact of higher doses on outcomes? Toxins. 2021;13(7):494. doi:10.3390/toxins13070494
   PubMed Web of Science ®Google Scholar
• Dayan S, Joseph J, Moradi A, et al. Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines. J Cosmet Dermatol. 2022;21(6):2407–2416. doi:10.1111/jocd.14906
   PubMed Web of Science ®Google Scholar
• Fabi SG, Carruthers J, Joseph J, et al. High-dose neuromodulators: a roundtable on making sense of the data in real-world clinical practice. Aesthet Surg J Open Forum. 2021;3(4):ojab036. doi:10.1093/asjof/ojab036
   PubMedGoogle Scholar